𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Experimental model in vivo for quantitative assessment of bone resorption inhibition

✍ Scribed by Dr. Ugo E. Pazzaglia; Giovanni Zatti; Amalia Di Nucci; Anna Coci; Paolo Cherubino

Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
562 KB
Volume
11
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Quantitative assessment of bone resorption inhibition in vivo is not easily accomplished; methods relying on a count of osteoclasts are questionable, and histomorphometric evaluation of the bone mass presents several technical problems as well. The authors developed a simple method to measure the inhibition of bone resorption by study of the proximal tibial metaphysis of growing rats: the height of the perichondrial bone ring was taken as an index of the balance between osteoblastic and osteoclastic activity because any agent that inhibits osteoclasts (without interference with osteoblasts) produces an increase in the height of this anatomical structure. Since the ring is well demarcated by surrounding tissues, its height can be measured with accuracy and used for quantitative assessment of bone resorption inhibition. This model was tested with salmon calcitonin, and it provides evidence in vivo that this hormone inhibits osteoclastic bone resorption.

πŸ“œ SIMILAR VOLUMES

Quantitative assessment of in vivo bone
Quantitative assessment of in vivo bone regeneration consolidation in distraction osteogenesis
✍ Henning Windhagen; Stefan Kolbeck; Hermann Bail; Arno Schmeling; Michael Raschke πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier Science 🌐 English βš– 806 KB

We present a new method for quantitatively assessing the consolidation of bone regeneration by performing distraction osteogenesis in micropigs. We measured in vivo stiffness using a newly developed, revolving, bone-healing meter. After the micropigs were killed, we obtained maximum torsional moment

Inhibition of bone resorption in vitro a
Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026)
✍ Kenneth J. Armour; Robert J. Van 't Hof; Katharine E. Armour; Anne C. Torbergsen πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 2 views

Objective. Inhibitors of prostaglandin production, such as nonsteroidal antiinflammatory drugs (NSAIDs), and pharmacologic nitric oxide (NO) donors, such as organic nitrates, have been suggested to protect against bone loss in both humans and experimental animals. Recently, a new class of nitrosylat